Alchem Laboratories Corporation
Alachua, FL Doing business as Alchem Laboratories Corp
- UEI
- LD2KY6H7KMQ5
- CAGE
- 3E3D1
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 325412 Pharmaceutical Preparation Manufacturing Primary
- 325180 Other Basic Inorganic Chemical Manufacturing
- 325199 All Other Basic Organic Chemical Manufacturing
- 325411 Medicinal and Botanical Manufacturing
- 325413 In-Vitro Diagnostic Substance Manufacturing
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- 541713 Research and Development in Nanotechnology
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- SAM.gov registration date
- Physical address
- 13305 Rachael Blvd, Alachua, FL 32615, USA
- Website
- alchem.com
- Founded
- 1997
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Screening and development of small molecule venezuelan equine encephalitis virus (veev) non- structural protein 2… | Defense Contract Management Agency | $955,424 | |
| The non-GMP synthesis of 100 grams of… | National Cancer Institute | $42,941 | |
| Synthesis of non-GMP small molecules - incrementally funded | National Cancer Institute | $1,249,540 | |
| Synthesis of up to ten sample compounds per year (continuity for 66C) | National Cancer Institute | $2,741,495 | |
| The purpose of this task order is the development and delivery of a quality assurance/quality control (QA/QC) plan and… | National Institute of Allergy and Infectious Diseases | $17,148 |
About Alchem Laboratories Corporation
Alchem Laboratories Corporation, doing business as Alchem Laboratories Corp, is a custom research organization that performs specialized services including custom organic synthesis, current Good Manufacturing Practice (cGMP) manufacturing, and analytical services. According to its website, Alchem Laboratories is engaged in pharmaceutical manufacturing. The company is registered as a corporate, for-profit manufacturer based in Florida.
Through prime federal contracts, Alchem Laboratories has primarily provided synthesis and analytical testing services for the National Cancer Institute and National Institute of Allergy and Infectious Diseases. Major contracts include a $2.9 million cost-plus-fixed-fee delivery order to synthesize non-GMP small molecule samples for the National Cancer Institute through 2027, and a $3.3 million order to similarly synthesize up to ten sample compounds per year for the Institute's Program 66C through 2026. The company has also received task orders totaling over $17 million under the Preclinical Services for HIV Therapeutics IDIQ to support therapeutic development for HIV/AIDS, providing services such as quality assurance planning, reagent programs, and therapeutic agent synthesis. No small business set-asides were designated for these prime contract awards to Alchem Laboratories.
Through prime federal grants, Alchem Laboratories has been awarded a $474,451 project grant by the Defense Threat Reduction Agency from 2023 to 2027 under the Scientific Research - Combating Weapons of Mass Destruction program. The grant will fund research and development of small molecule inhibitors targeting the Venezuelan equine encephalitis virus, aimed at developing potential medical countermeasures against this biological threat agent.
Alchem Laboratories holds multiple federal indefinite delivery vehicle (IDV) contracts that specify the types of preclinical and manufacturing services the company can provide across task orders. This includes a $12 million National Cancer Institute IDV through 2028 for analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations to advance the Institute's cancer research. Alchem is also one of multiple awardees on the $107 million Preclinical Services for HIV Therapeutics IDV awarded by the National Institute of Allergy and Infectious Diseases, through which it will provide services across seven task areas including in vitro testing, small molecule synthesis, animal studies, formulation development, and more. The company additionally has roles on IDVs held by other NIH offices focused on drug formulation and manufacturing support, as well as medicinal chemistry lead optimization services awarded through the National Center for Advancing Translational Sciences.
Contract vehicles
Quick answers
What is Alchem Laboratories Corporation's UEI?
Alchem Laboratories Corporation's Unique Entity ID (UEI) in SAM.gov is LD2KY6H7KMQ5.
What is Alchem Laboratories Corporation's CAGE code?
Alchem Laboratories Corporation's CAGE code is 3E3D1.
What is Alchem Laboratories Corporation's primary NAICS code?
Alchem Laboratories Corporation's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Alchem Laboratories Corporation located?
Alchem Laboratories Corporation's physical address in SAM.gov is 13305 Rachael Blvd, Alachua, FL 32615, USA.
Is Alchem Laboratories Corporation registered in SAM.gov?
Alchem Laboratories Corporation's SAM.gov registration expired on September 16, 2026.
Which contract vehicles does Alchem Laboratories Corporation hold?
Alchem Laboratories Corporation holds a place on 5 federal contract vehicles, including Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products and Preclinical Services for HIV Therapeutics.
What is Alchem Laboratories Corporation's most recent federal award?
Alchem Laboratories Corporation's most recent federal grant award is Screening and development of small molecule venezuelan equine encephalitis virus (veev) non- structural protein 2… (HDTRA12410002), from Defense Contract Management Agency, on October 30, 2023.
On GovTribe
See Alchem Laboratories Corporation's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors